PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 206 filers reported holding PDL BIOPHARMA INC in Q4 2015. The put-call ratio across all filers is 0.15 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $94,000 | +4.4% | 18,706 | +32.2% | 0.02% | +11.8% |
| Q2 2015 | $90,000 | -7.2% | 14,146 | +2.2% | 0.02% | -5.6% |
| Q1 2015 | $97,000 | -12.6% | 13,846 | -4.6% | 0.02% | -14.3% |
| Q4 2014 | $111,000 | +11.0% | 14,509 | +7.4% | 0.02% | +5.0% |
| Q3 2014 | $100,000 | -11.5% | 13,509 | +15.6% | 0.02% | +11.1% |
| Q2 2014 | $113,000 | +18.9% | 11,691 | +1.7% | 0.02% | -10.0% |
| Q1 2014 | $95,000 | -3.1% | 11,491 | -1.7% | 0.02% | -13.0% |
| Q4 2013 | $98,000 | +10.1% | 11,691 | +4.6% | 0.02% | 0.0% |
| Q3 2013 | $89,000 | +3.5% | 11,181 | 0.0% | 0.02% | -11.5% |
| Q2 2013 | $86,000 | – | 11,181 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SMH CAPITAL ADVISORS INC | 81,713 | $176,000 | 0.39% |
| BRANDES INVESTMENT PARTNERS, LP | 5,465,156 | $11,805,000 | 0.30% |
| Crestline Management, LP | 875,000 | $1,890,000 | 0.30% |
| West Family Investments, Inc. | 539,450 | $1,165,000 | 0.29% |
| WEBER ALAN W | 200,000 | $432,000,000 | 0.19% |
| Zebra Capital Management LLC | 73,910 | $160,000 | 0.18% |
| RBF Capital, LLC | 569,323 | $1,230,000 | 0.14% |
| Leap Investments LP | 69,496 | $150,000 | 0.08% |
| Connor, Clark & Lunn Investment Management Ltd. | 4,387,038 | $9,476,000 | 0.06% |
| CHICAGO EQUITY PARTNERS LLC | 519,315 | $1,122,000 | 0.05% |